Insurers
Mitigate risk and accelerate underwriting analysis.
Medical devices and pharmaceutical products can include significant safety risks to both patients and clinicians. Underwriting, client account monitoring, and risk mitigation processes require clinician knowledge to be optimally informed. Med Safety Board (MSB)—powered by ECRI and the Institute for Safe Medication Practices (ISMP)—provides unparalleled global expertise in product safety, enabling underwriting teams to understand common pitfalls associated with these products.
Leverage clinical expertise to address coverage risks
MSB product safety experts are actual end-user clinicians (PharmD, MD, RN) and clinically informed human factors engineers with decades of direct patient-facing experience. With exclusive access to error databases across ECRI and ISMP, in addition to government error reporting programs, our experts can effectively pinpoint and address risks previously reported across drug classes and medical-device types. Whether reviewing clinical trial protocols or evaluating labeling and packaging, we deliver reliable solutions to mitigate coverage risks.
Exclusive access
ISMP’s MERP database and extensive partner network of end-user clinicians for feedback.
Leverages
ISMP's and ECRI's more than 50 years of experience in medical-device and medication-safety evaluation and error prevention.
In-house
Product safety experts who are actual clinicians (PharmD, RN, etc.), and human factors engineers.
Comprehensive underwriting and risk control solutions
Gain insight into disease states, product functionality, and user applications. Our experts analyze labeling, packaging, and instructions for use, perform risk assessments, and conduct human factors studies—delivering actionable data for better-informed underwriting and coverage decisions.
Clinical Trial Risk Assessment
Expedite your understanding of patient risks associated with clinical trial participation. Product safety experts provide evaluations and education on trial protocols, informed consent agreements, and trial materials to mitigate risks effectively.
Risk-Benefit Assessment
Assess clinical trial patient risks versus potential outcomes. MSB reviews trial materials for patient/caregiver understanding and reports on preestablished risks for similar products in the market.
Clinician Use-Related Risk Analysis (URRA)
Understand how manufacturer products are used in the market. Our analysis helps identify use-related risks, reducing negative patient outcomes.
Labeling and Packaging Review
Identify patient safety risks associated with product-label and packaging confusion, one of the most common types of voluntary reports submitted to the ISMP National Medication Errors Reporting Program.
Get in Touch
Let's start zeroing in on exactly how we can help.
More Ways We Help
Product Safety Advisory Boards
Gather actionable end-user feedback from clinicians to identify risks, optimize designs, and improve product safety and outcomes.
Learn More
Product and Medication-Use Error Briefings
Utilize exclusive error data and targeted research to identify and address product safety risks, ensuring safer products.
Learn More
Insights and Qualitative Research
Collaborate with experts to gather data-driven insights, identify safety concerns, and improve pharmaceutical and device safety.
Learn More
Best Practices Training
Equip your team with expert-led, tailored training to enhance safety, reduce risks, and ensure compliance throughout product development.
Learn More
Trademark Name and Safety Testing
Proactively evaluate pharmaceutical brand names to identify look-alike and sound-alike risks, minimizing medication errors and confusion.
Learn More